Table 1.
Zebrafish | Mouse | Fly | Worm | |
---|---|---|---|---|
Transparency | Fully transparent at embryonic stage and remain translucency through adulthood. PTU can be used to inhibit pigmentation during early embryonic development. Mutant fish line without pigments are available. |
Not transparent | Transparent in larva stage and some parts of the adults | Transparent No pigmentation |
Offspring size per mating | Up to 100 | ~3–12 | Up to 500 | Hermaphrodites, varies |
Genetic similarity (humans genome as reference) |
71% | 85% | 50% | 52% |
Immune System | Underdeveloped adaptive immune system in larvae | Intact | Does not possess acquired/adaptive immunity | Does not possess acquired/adaptive immunity |
Tumor visualization | Directly visualized in vivo by microscopy | Cannot be easily visualized inside the body | Directly visualized in vivo by microscopy | Directly visualized in vivo by microscopy |
Gene editing tools | ||||
Morpholino | Established | Feasible but very limited | Possible but not done yet | Possible but not done yet |
Retroviral insertion mutagenesis screen | Feasible | Established | Feasible | Feasible |
DNA co-injection (I-SceI) Transgenesis | Established, high efficiency | Hypothetical and not efficient | Hypothetical | Possible |
CRISPR/TALENs | Established | Established | Established | Established |
Tumor transplantation/Xenograft application | Efficient | Moderate to difficult | N/A | N/A |
Chimeric animal development | Mouse-zebrafish Chimeric | Human-mouse Chimeric | N/A | N/A |
Syngeneic model | Yes | Yes | Yes | N/A |
Drug screening | Established, high-throughput | Established, low-throughput | Established, high-throughput | Established, high-throughput |